to survive drug treatment, which is generally effective against the same species at the same stage of infestation at an identical dosage level (World Health Organization, 2011) has become comonly reported. One of the biggest concern is the resistance against benzimidazole compounds (Cernea et al., 2010) , associated, for example, to single nucleotide polymorphisms in the β-tubulin isotype 1 gene (VianaFurtado et al., 2014) .
The present paper aims was to evaluate the efficacy of selected members of benzimidazole, tetrahydropyrimidine and macrocyclic lactone anthelmintics groups against canine hookworms.
Materials and methods
In order to test in vitro the efficacy of anthelmintic substances used for the treatment of hookworms, we conducted a study on 62 dogs living in rural regions of Cluj County, between March and December 2017. We tested in vitro the ovicidal and larvicidal effects of four benzimidazole compounds: albendazole (ABZ), mebendazole (MBZ), fenbendazole (FBZ) and flubendazole (FLU). We also tested the larvicidal effects of pyrantel (PYR) from tetrahydropyrimidine group as well as selamectin (SEL) from macrocyclic lactone group. The in vitro tests were performed by using Egg Hatch Assay (EHA) and Larval Development Assay (LDA). From each individual, fresh faecal samples were collected and a mixed sample was obtained. The Ancylostomatidae eggs were collected from this mixed sample by flotation methods. The techniques were performed within the Pharmacovigilance Laboratory of Cluj-Napoca Veterinary Medicine Faculty as per protocol of Le Jambre (1978) .
The total number of eggs per milliliter was determined by using the formula:
Eggs/ml = (1000 x no. eggs per 50µl) / 50
We used EHA in order to assess the ovicidal properties of the benzimidazole compounds: albendazole (ABZ), mebendazole (MBZ), fenbendazole (FBZ) and flubendazole (FLU). For each active drug, serial mother solutions were obtained, ranging from 500 mcg to 0.98 mcg active drug/ml. The samples were placed in 2 ml well plates. For each compound, 10 wells of successively diluted active drugs were used, containing 790 μl of distilled water, 200 µl of egg suspension, containing about 500 parasite eggs, and 10 µl diluted active drug solutions. The final testing solutions had active drug concentrations ranging from 5.0 to 0.0098 mcg/ml. Two negative controls were used, M 1 consisting of 200 µl egg suspension, containing about 500 parasite eggs, and 800 µl distilled water and M 2 consisting of 790µl distilled water, 200 µl egg suspension, containing about 500 parasite eggs, and 10 µl of HCl solution. The M2 control was used only for testing benzimidazoles, because of the fact that these active drugs, have to be dissolved in hydrochloric acid before mixing them with water.
The samples were kept in the thermostat at 27ºC for 24 hours and assessed by counting the embryonated and unembryonated eggs as well as the hatched larvae. The egg hatching percentage was determined applying the formula:
Egg hatching % = [(EE + L 1 ) / ( UE + EE + L 1 )] x 100
(Le Jambre et al., 1978 , Coles et al., 1992 , where EE signifies the embryonated eggs, L 1 represents larvae L 1 and UE signifies unembryonated eggs.
Larval development assay (LDA) was used to test larvicidal effects of albendazole (ABZ), mebendazole (MBZ), fenbendazole (FBZ), flubendazole (FLU), pyrantel (PYR) and selamectin (SEL). The dilution protocol was identical to the one used for EHA, and the final testing solutions had the same active drug concentrations ranging from 5.0 to 0.0098 mcg/ml. The test had a duration of 14 days in order to culture eggs trough the L3 stage.Samples were kept in thermostat at 27ºC for 14 days. For this assay the minimum inhibitory concentration (MIC) was obtained by calculating the larval development percentage, applying the formula:
where L 3 represents the number of L 3 larvae and UE stands for unembryonated eggs, as per protocole of Coles et al. (1988 
Results and discussions
In EHA, for ABZ high hatching percentages were found in all used concentrations. The minimum value was recorded at 5 mcg/ml concentration, for which the egg hatching percentage was 14.29%. Consequently, the a parameter value was -7.1 and the b parameter 102.13, determining a positive Y max value (66.63) ( Table 1) .
As a result, the efficacy of ABZ on Ancylostomatidae eggs is low, this being also highlighted by the high value of EC 50 (7.33450 mcg/ml). The Y parameter values determined for all concentrations used in ABZ, revealed a slightly negative trend of the regression line, which indicates an average risk of installing adaptive phenomena. At the reference concentration of 0.15 mcg/ml, Egg hatching percentage was 101.07%, well above the maximum limit considered as resistance threshold (50%) ( Table 1) .
A similar situation was also revealed in MBZ testing. The minimum egg hatching percentage was recorded at 5 mcg/ml concentration (59.52%), while at reference concentration, it was 100.43%, showing thet MBZ had limited efficacy on the studied helminths. EC 50 doubled compared to the one obtained for ABZ (15.189 mcg/ml). The regression line had a slightly negative trend, the value of Y max. parameter being 84.18 ( Table 1) .
The results obtained with FBZ in the case of EHA have highlighted a situation similar to that found in ABZ and MBZ. The egg hatching percentage at reference concentration being 99.38%, with EC50 6.66240 mcg/ml. The maximum value of Y parameter was 62.62, which implied a slight negative trend for the regression line ( Table 1) . The FLU testing for Ancylostomatidae eggs, revealed the worst efficacy compared to the other benzimidazoles. The egg hatching percentage at reference concentration was 100.11%, with EC 50 20.2804 mcg/ml. As a result the regression line tendency ranged between 88.08 and 100 (Table  1) .
LDA testing of the benzimidazoles revealed improved efficacy compared to EHA tests. These results are due to the longer contact time between anthelmintic substances and parasitic forms, benzimidazoles having both ovicidal and larvicidal actions (Cernea et al., 2010) .
In ABZ testing by LDA, the percentage of larval development inhibition varied according to the active drug concentration, being maximum at 2.5 mcg/ml, respectively 0.625 mcg/ml (0%) concentrations. Minimal percentage of larval development inhibition was recorded at the concentrations of 0.0781 mcg/ml, respectively 0.0098 mcg/ml (100%). The trend of the regression line, influenced by Y parameter values, was negative, the maximum being 33.16. MIC when tested by using the ARP programe a had a value of 8.4675 mcg/ml (Table 2 ).
In the case of MBZ testing by LDA, the results obtained are much better compared to those obtained at EHA. It is noted that the prolongation of the contact time between parasitic forms and MBZ determines its high efficacy. The larval development inhibition percentage at the minimal concentration (0.0098 mcg/ml) was 12.50%. The effectiveness of MBZ is also highlighted by the low MIC, which is 0.86720 mcg/ml. Due to the high efficacy of MBZ, the regression line trend is negative, the value of the Y max. parameter being -64.14 ( Table 3) .
Improvement of anthelmintic efficacy was also noted in the case of FBZ, the MIC being of 1.9630 mcg/ml. Larvae development was completely inhibited at concentrations between 5 and 1.25 mcg/ml, respectively 0.1563 mcg/ CĂTANĂ et al ml. Maximum percentages of larval development (33,33%), were recorded at lower concentrations (0.0391 and 0.0195 mcg/ml). The negative value of a parameter (-9,39), influenced the value of Y, that had a maximum of -27.89. Due to these values, the regression line tendency is negative (Table 2 ). In the LDA tests, FLU presented the lowest efficacy. The complete inhibition of L3 was noted only at the concentration of 0.6250 mcg/ml. The maximum value of development percentage (90%), was recorded at concentration of 0.0195 mcg/ml. The maximum value of Y parameter was -1.96, and MIC 4.4272 mcg/ml. As a result, although the trend of the regression line was negative, we can assume that in the case of FLU, the parasites from Ancylostomatidae family are susceptible to resistance ( Table 2) .
The best results for the LDA tests, respectively the highest efficacy, were obtained in the case of PYR. The larval development inhibition percentage was maximal at concentrations of 5, 0.3125, 0.1563 and 0.0391 mcg/ml, determining the calculation of a 0.2131 mcg/ml MIC. Compared with other tested active drugs, due to the values of the parameters a and b, Y max parameter had the lowest value (-448.37). Consequently, the regression line had a strong negative trend, which reveals a low risk of resistance of the studied parasites to PYR-based anthelmintics (Table 3) .
SEL completely inhibited the development of L3 larvae at concentrations ranging from 5 to 0.3125 mcg/ml and MIC was 2.7921 mcg/ml. These data show the good efficacy of SEL against parasites from Ancylostomatidae family, but lower compared to PYR. The regression line equation recorded for the Y max. parameter a higher value than for PYR (-62.74 the fact that the studied parasitic population is highly susceptible for emergence of ABZ-resistant individuals.
The active drugs with the lowest susceptibility to inducing resistance were MBZ, PYR and SEL. Improvement in anthelmintic efficacy has also been noted in FBZ, MIC being 1.9630 mcg/ml and larvae development being completely inhibited at concentrations between 5 and 1.25 mcg/ml, respectively 0.1563 mcg/ml.
The regression lines obtained in EHA and LDA tests, correlate with EC 50 and MIC values. EC 50 with the lowest value was obtained for the EHA with FBZ (6.6624 mcg/ml). From this point of view, the lowest efficacy was recorded for FLU (20.2804 mcg/ml) and MBZ (15.1892 mcg/ml).
For PYR test, a concentration of 0.2131 mcg/ ml was sufficient to completely inhibit larval development in LDA test. For SEL the MIC was 2.7921 mcg/ml. For the benzimidazole compounds the lowest MIC values were noted at MBZ (0.8672 mcg/ml).
Due to the fact that active drugs with different action mechanisms have different MIC, it is not correct to compare the efficacy of these substances with the resulting MIC. Comparisons can only be made by correlations between EC50, MIC and the regression line trend.
As a result, taking into account the three elements, the highest efficacy and the minimum risk of adaptive phenomena induction for the tested parasites from the Ancylostomatidae family are PYR, SEL, MBZ, and FBZ. ABZ is not recommended to be used for hookworm treatments in the animals used in the study.
The benzimidazoles pharmacological activity is based on the binding to parasite β-tubulin, which produces subsequent disruption of the tubulinmicrotubule dynamic equilibrium. Additionally, the inhibition of secretion of nematode acetylcholinesterase and inhibition of some enzymatic activities (such as fumarate reductase, malate dehydrogenase, phosphoenol pyruvate reductase, and succinate dehydrogenase) have been associated with the BZD anthelmintic action (Lacey, 1990; Riviere and Papich, 2018) . The fact that the benzimidazoles compounds presented improved efficacy if the parasitic forms are kept longer time in contact with the active ingredients is due to their ovicidal and larvicidal actions, being stated also by other researches (Cernea et al., 2010 , Cristina, 1997 .
For albendazole, due to intense liver metabolism and transformation into active metabolites, with the involvement of the cytochrome P450 and flavin monooxygenase systems, efficacy can be much greater when tested in vivo compared to in vitro (Cernea et al., 2010; Riviere and Papich, 2018) .
Selamectin action mechanism against nematodes is by inducing paralytic effects on the parasite somatic musculature and on the pharyngeal pump which affects nutrients ingestion. The paralytic effects are mediated through GABA and glutamate-gated chloride channels. They are considered as extremely effective against adult and larval stages of most gastrointestinal nematodes (Riviere and Papich, 2018) .
Selamectin eficacy against hookworms is mentioned in various research in the field of parasitology, being considered as a very good antiparasitic molecule both for dogs and cats (Bishop et al., 2000; McTier et al., 2000; Geurden et al., 2017) .
In the case of macrocyclic lactones treatments, the risk of treating MDR1 genetically defective dogs should also be taken into account. Selamectin use is considered safe in ivermectin sensitive Collie dogs (Riviere and Papich, 2018) . Changes in the glutamategated chloride channels structure and an increased expression of different proteins involved in drug efflux (P-GP) have been postulated as the main mechanism of resistance to macrocyclic lactones in nematodes (Riviere and Papich, 2018) .In our research, for the tested parasites, we found no risk in inducing addaptative phenomena against this active drug.
The larvicidal effects of tetrahydropyrimidine compounds are due to their selective action as agonists at synaptic and extrasynaptic nicotinic acetylcholine receptors (nAChR) on nematode muscle cells. They produce contractions and spastic paralysis, mimicking the paralytic effects of excessive acetylcholine amounts. Pyrantel is poorly absorbed from the GI tract. The drug is considered to be highly effective against mature worms and larval stages (Cernea et al., 2015; Riviere and Papich, 2018) .
Drug combinations are often recommended for their better efficacy and for lowering the risks of resistance phenomena, often we see
In Vitro Study of Benzimidazole Derivatives, Tetrahydropyrimidines and Macrocyclic Lactones Therapeutic Efficacy recomendations of macrocyclic lactones, pyrantel and fenbendazole (Wright, 2009; Miro et al., 2007; Clark et al., 1992; Shoop et al., 1996) .
On the other hand, empirical use anthelmintics, without consulting the veterinarian, may lead in the near future to the emergence of resistant strains that will complicate the therapeutic protocol, increase the risk of dissemination, and consequently increase the number of infected animals and even people, as these ancylostomatids worms show zoonotic potential (Brenner and Patel, 2003; Croese et al., 1994) .
This type of efficacy and resistance prediction tests are recommended to be performed at least once a year due to the ability of parasites to adapt to drug therapy in a relatively short time.
Conclusions
Ovicidal effects of benzimidazole group substances was low, indicating the resistance potential of hookworms to these substances is very high except for FBZ, with lower resistance risk.
The larvicidal effects of benzimidazole group substances, were better compared to the ovicidal effects, with the exception of albendazole.
The risk of inducing resistance phenomena against bezimidazole compounds proved to be lower if the parasitic forms are kept longer time in contact with the active drug testing solutions.
Pyrantel and Selamectin have proven to be very effective against the tested parasites, also presenting minimal risks of resistance phenomena induction. These active drugs, through proven efficacy, are recommended for use as antihelminthics against digestive strongylidoses in the studied dogs, being a good alternative in case of benzimidazole resistance.
